J7627 Budesonide comp unit

Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg

• Medicare coverage: Carrier judgment
• Status: active (July 2026 file)
• MUE: max 0 units per day (practitioner), rationale: Compounded Drug Policy